MEDICOX Co. Ltd
MEDICOX Co., Ltd. operates in the shipbuilding equipment, electric motor, and generator businesses in South Korea and internationally. It produces blocks, such as bows, sterns, propeller bosses, and engine rooms for very large ships; and generators for ship power generation, as well as motors and traction motors. The company is also involved in the provision of customized manufacturing services, … Read more
MEDICOX Co. Ltd (054180) - Total Assets
Latest total assets as of March 2025: ₩83.56 Billion KRW
Based on the latest financial reports, MEDICOX Co. Ltd (054180) holds total assets worth ₩83.56 Billion KRW as of March 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
MEDICOX Co. Ltd - Total Assets Trend (2012–2024)
This chart illustrates how MEDICOX Co. Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
MEDICOX Co. Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
MEDICOX Co. Ltd's total assets of ₩83.56 Billion consist of 16.3% current assets and 83.7% non-current assets.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 1.5% |
| Accounts Receivable | ₩2.14 Billion | 2.6% |
| Inventory | ₩1.05 Billion | 1.3% |
| Property, Plant & Equipment | ₩0.00 | 0.0% |
| Intangible Assets | ₩16.25 Million | 0.0% |
| Goodwill | ₩0.00 | 0.0% |
Asset Composition Trend (2012–2024)
This chart illustrates how MEDICOX Co. Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: MEDICOX Co. Ltd's current assets represent 16.3% of total assets in 2024, an increase from 5.6% in 2012.
- Cash Position: Cash and equivalents constituted 1.5% of total assets in 2024, up from 1.4% in 2012.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2012.
- Asset Diversification: The largest asset category is accounts receivable at 2.6% of total assets.
MEDICOX Co. Ltd Competitors by Total Assets
Key competitors of MEDICOX Co. Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Oriental Precision & Engineering Co.Ltd
KQ:014940
|
Korea | ₩233.15 Billion |
|
Victek Co. Ltd
KQ:065450
|
Korea | ₩127.38 Billion |
|
SAMYUNG ENC Co. Ltd
KQ:065570
|
Korea | ₩74.14 Billion |
|
AeroSpace Technology of Korea
KQ:067390
|
Korea | ₩566.04 Billion |
|
Satrec Initiative Co. Ltd
KQ:099320
|
Korea | ₩371.73 Billion |
|
Inhwa Precision Co. Ltd
KQ:101930
|
Korea | ₩463.17 Billion |
|
Hizeaero Co. Ltd
KQ:221840
|
Korea | ₩114.85 Billion |
|
Kencoa Aerospace Corporation
KQ:274090
|
Korea | ₩249.04 Billion |
MEDICOX Co. Ltd - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - MEDICOX Co. Ltd generates 0.38x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - MEDICOX Co. Ltd is currently not profitable relative to its asset base.
MEDICOX Co. Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.74 | 1.01 | 0.36 |
| Quick Ratio | 0.68 | 0.94 | 0.32 |
| Cash Ratio | 0.21 | 0.00 | 0.00 |
| Working Capital | ₩-5.82 Billion | ₩ 311.09 Million | ₩ -11.95 Billion |
MEDICOX Co. Ltd - Advanced Valuation Insights
This section examines the relationship between MEDICOX Co. Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.23 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -15.8% |
| Total Assets | ₩81.42 Billion |
| Market Capitalization | $442.04K USD |
Valuation Analysis
Below Book Valuation: The market values MEDICOX Co. Ltd's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: MEDICOX Co. Ltd's assets decreased by 15.8% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for MEDICOX Co. Ltd (2012–2024)
The table below shows the annual total assets of MEDICOX Co. Ltd from 2012 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | ₩81.42 Billion | -15.79% |
| 2023-12-31 | ₩96.69 Billion | -12.44% |
| 2022-12-31 | ₩110.43 Billion | +7.76% |
| 2021-12-31 | ₩102.48 Billion | +20.72% |
| 2020-12-31 | ₩84.89 Billion | +43.51% |
| 2019-12-31 | ₩59.15 Billion | +5.51% |
| 2018-12-31 | ₩56.06 Billion | +6.88% |
| 2017-12-31 | ₩52.45 Billion | -5.11% |
| 2016-12-31 | ₩55.28 Billion | +16.37% |
| 2015-12-31 | ₩47.50 Billion | -0.31% |
| 2014-12-31 | ₩47.65 Billion | +2.64% |
| 2012-12-31 | ₩46.42 Billion | -- |